Genentech and PatientsLikeMe enter Broad Partnership Surrounding Patient Database

PatientsLikeMe is an online patients-centered online network with a database of approximately 250,000 members, who share information about disease progression, treatment options and outcomes, as well as quality of care. ALS is one of the largest patient groups in the database, but over 2000 diseases are represented. This extensive patient data is a potential goldmine for drug companies seeking to collect medical evidence from patients and to learn about their unmet needs. Genentech, which was acquired in 2009 by the Swiss drug company Roche, has entered a five-year partnership with PatientsLikeMe that allows them broad access to the full database of de-identified data for the next five years.

PatientsLikeMe is an online patients-centered online network with a database of approximately 250,000 members, who share information about disease progression, treatment options and outcomes, as well as quality of care. ALS is one of the largest patient groups in the database, but over 2000 diseases are represented. This extensive patient data is a potential goldmine for drug companies seeking to collect medical evidence from patients and to learn about their unmet needs. Genentech, which was acquired in 2009 by the Swiss drug company Roche, has entered a five-year partnership with PatientsLikeMe that allows them broad access to the full database of de-identified data for the next five years.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail